SoftGenetics

The integrated products will provide a seamless workflow for interpreting next-generation sequence data from alignment through pathway analysis.

SoftGenetics said this week that its GeneMarker Human Identity software has received NDIS approval from the Federal Bureau of Investigation.

CollabRx has launched CancerRx, a new oncology application that runs on Apple's operating system. The app provides oncologists and pathologists with treatment options that are based on their patients' tumors and also offers a daily newsfeed from MedPage Today.

The National Center for Biotechnology Information has updated its Sequence Viewer tool.

Genedata has released a new version of Genedata Expressionist for Mass Spectrometry, its software for the analyzing metabolomics data.
Version 8.0 includes new workflows for integrated processing of LC- and GC-MS data.

Foundation Medicine has launched FoundationOne Heme, a next-generation sequencing-based test that looks for genomic alterations in 405 genes related to hematological cancers. The test also incorporates RNA sequencing of 265 genes to look for gene fusions.

SoftGenetics has released the latest version of its NextGene software for analyzing next-generation sequence data.

NuGen Technologies has launched its Ovation Human FFPE RNA-seq Multiplex System, which provides an end-to-end solution for strand-specific RNA-seq library prep from formalin-fixed paraffin-embedded tissue.

SoftGenetics has added a copy number variation tool to its NextGene software.

Pages

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.